+91-22-66638220 / 21/ 22

Biocon opens new facility to make insulin devices in India

Industry Drugs & Pharmaceuticals

Biocon has opened one-lakh-sq-ft new insulin devices manufacturing facility in India. The facility has the capacity to manufacture 10 million devices a year. Other details are not disclosed.

Extracted from HBL, Sep 15,’15

Sales Skills Test


Sign up to receive from Domex's e-Shop

Special subscription offers and free sample e-bulletins.

12 different e-bulletins in Excel & PDF available